Cargando…
Using Cytochalasins to Improve Current Chemotherapeutic Approaches
Although the amount of progress cancer therapy has made in recent years is commendable, considerable limitations still remain. Most agents preferentially target rapidly proliferating cells, thereby destroying tumorigenic growths. Unfortunately, there are many labile cells in the patient that are als...
Autor principal: | Trendowski, Matthew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485394/ https://www.ncbi.nlm.nih.gov/pubmed/25322987 http://dx.doi.org/10.2174/1871520614666141016164335 |
Ejemplares similares
-
Chemotherapy with cytochalasin congeners in vitro and in vivo against murine models
por: Trendowski, Matthew, et al.
Publicado: (2015) -
Preparation, In Vivo Administration, Dose-Limiting Toxicities, and Antineoplastic Activity of Cytochalasin B
por: Trendowski, Matthew, et al.
Publicado: (2015) -
Effects of cytochalasin congeners, microtubule-directed agents, and doxorubicin alone or in combination against human ovarian carcinoma cell lines in vitro
por: Trendowski, Matthew, et al.
Publicado: (2015) -
Chemotherapy in vivo against M109 murine lung carcinoma with cytochalasin B by localized, systemic, and liposomal administration
por: Trendowski, Matthew, et al.
Publicado: (2015) -
Effects of cytochalasin and phalloidin on actin
Publicado: (1987)